Bjorn Knollmann
-
VUMC joins research network to fight atrial fibrillation
Vanderbilt University Medical Center (VUMC) has been selected by the American Heart Association (AHA) to participate in a six-member research network to advance treatment and prevention of atrial fibrillation (AFib), an irregular heart rate that increases the risk of stroke and other heart-related complications. Read MoreJun 14, 2018
-
Six Vanderbilt physicians honored by medical societies
Four faculty members of Vanderbilt University School of Medicine were among 78 physician-scientists inducted into The American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. They are: Read MoreMay 3, 2018
-
Nine new endowed chair recipients honored
Nine Vanderbilt University faculty members named to endowed chairs were honored during a celebration at the Student Life Center Feb. 28. Read MoreMar 5, 2018
-
Knollmann to direct new arrhythmia research center
Björn Knollmann, M.D., Ph.D., has been named director of the newly formed Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART). Read MoreJan 14, 2016
-
New method aids heart disease studies, drug discovery efforts
A team of Vanderbilt investigators developed a new method for rapidly generating heart muscle cells from stem cells. Read MoreJan 14, 2016
-
Normalizing calcium flux to treat atrial fibrillation
A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation. Read MoreMay 12, 2014
-
Reducing fatal rhythms after heart attack
Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks. Read MoreJul 26, 2013
-
Green tea for failing hearts?
The main antioxidant compound in green tea increases contractile force in isolated heart cells, suggesting it may be useful in heart failure. Read MoreNov 16, 2012